{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:19:37Z","timestamp":1770909577713,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,9]]},"DOI":"10.7759\/cureus.57943","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T06:25:05Z","timestamp":1712730305000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparative and Predictive Significance of Serum Leptin Levels in Non-alcoholic Fatty Liver Disease"],"prefix":"10.7759","author":[{"given":"Mehwish","family":"Qamar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambreen","family":"Tauseef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad I","family":"Yousufzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Liaqat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qanbar","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Comparison of serum ferritin levels in nafld patients and healthy controls","volume":"70","author":"Qamar M","year":"2020","unstructured":"Qamar M, Fatima SA, Khan HA, Khan QU, Nadeem A, Sikandar H. Comparison of serum ferritin levels in nafld patients and healthy controls. Pak Armed Forces Med J. 2020, 70:1782-86.","journal-title":"Pak Armed Forces Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","volume":"7","author":"Chait A","year":"2020","unstructured":"Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020, 7:22. 10.3389\/fcvm.2020.00022","journal-title":"Front Cardiovasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112704","article-title":"Leptin, obesity, and leptin resistance: where are we 25 years later?","volume":"11","author":"Izquierdo AG","year":"2019","unstructured":"Izquierdo AG, Crujeiras AB, Casanueva FF, Carreira MC. Leptin, obesity, and leptin resistance: where are we 25 years later?. Nutrients. 2019, 11:2704. 10.3390\/nu11112704","journal-title":"Nutrients"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD single topic conference","volume":"37","author":"Neuschwander-Tetri BA","year":"2003","unstructured":"Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology. 2003, 37:1202-19. 10.1053\/jhep.2003.50193","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3050","article-title":"Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes","volume":"34","author":"Cernea S","year":"2018","unstructured":"Cernea S, Roiban AL, Both E, Hu\u0163anu A. Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes. Diabetes Metab Res Rev. 2018, 34:e3050. 10.1002\/dmrr.3050","journal-title":"Diabetes Metab Res Rev"},{"key":"ref6","unstructured":"United States military body fat standards. (2020). Accessed. February 21, 2024: https:\/\/www.liveabout.com\/united-states-military-body-fat-standards-3356944."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i8.1219","article-title":"NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients","volume":"19","author":"Treeprasertsuk S","year":"2013","unstructured":"Treeprasertsuk S, Bj\u00f6rnsson E, Enders F, Suwanwalaikorn S, Lindor KD. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. World J Gastroenterol. 2013, 19:1219-29. 10.3748\/wjg.v19.i8.1219","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070762","article-title":"Role of leptin in non-alcoholic fatty liver disease","volume":"9","author":"Jim\u00e9nez-Cortegana C","year":"2021","unstructured":"Jim\u00e9nez-Cortegana C, Garc\u00eda-Galey A, Tami M, et al.. Role of leptin in non-alcoholic fatty liver disease. Biomedicines. 2021, 9:762. 10.3390\/biomedicines9070762","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2018.0011","article-title":"The association of leptin with severity of non-alcoholic fatty liver disease: a population-based study","volume":"24","author":"Rotundo L","year":"2018","unstructured":"Rotundo L, Persaud A, Feurdean M, Ahlawat S, Kim HS. The association of leptin with severity of non-alcoholic fatty liver disease: a population-based study. Clin Mol Hepatol. 2018, 24:392-401. 10.3350\/cmh.2018.0011","journal-title":"Clin Mol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.01.010","article-title":"Diabetes liver fibrosis score to detect advanced fibrosis in diabetics with nonalcoholic fatty liver disease","volume":"20","author":"Singh A","year":"2022","unstructured":"Singh A, Garg R, Lopez R, Alkhouri N. Diabetes liver fibrosis score to detect advanced fibrosis in diabetics with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2022, 20:e624-6. 10.1016\/j.cgh.2021.01.010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2022.1434","article-title":"The impact of insulin resistance on hepatic fibrosis among United States adults with non-alcoholic fatty liver disease: NHANES 2017 to 2018","volume":"37","author":"Bae JC","year":"2022","unstructured":"Bae JC, Beste LA, Utzschneider KM. The impact of insulin resistance on hepatic fibrosis among United States adults with non-alcoholic fatty liver disease: NHANES 2017 to 2018. Endocrinol Metab (Seoul). 2022, 37:455-65. 10.3803\/EnM.2022.1434","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-022-01419-w","article-title":"Non-alcoholic fatty liver disease and liver secretome","volume":"45","author":"Khan MS","year":"2022","unstructured":"Khan MS, Lee C, Kim SG. Non-alcoholic fatty liver disease and liver secretome. Arch Pharm Res. 2022, 45:938-63. 10.1007\/s12272-022-01419-w","journal-title":"Arch Pharm Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.683250","article-title":"Adiponectin, leptin, and IGF-1 are useful diagnostic and stratification biomarkers of NAFLD","volume":"8","author":"Marques V","year":"2021","unstructured":"Marques V, Afonso MB, Bierig N, et al.. Adiponectin, leptin, and IGF-1 are useful diagnostic and stratification biomarkers of NAFLD. Front Med (Lausanne). 2021, 8:10.3389\/fmed.2021.683250","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.51253\/pafmj.v73iSUPPL-1.11365","article-title":"Serum ferritin; a strong non-invasive predictor for nafld progression","volume":"73","author":"Qamar M","year":"2023","unstructured":"Qamar M, Tauseef A, Naqvi QA, Ehsan K, Anwar R, Fatima SA. Serum ferritin; a strong non-invasive predictor for nafld progression. PAFMJ. 2023, 73:462-7. 10.51253\/pafmj.v73iSUPPL-1.11365","journal-title":"PAFMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1287916","article-title":"Association between nonalcoholic fatty liver disease and increased glucose-to-albumin ratio in adults without diabetes","volume":"14","author":"Wang S","year":"2023","unstructured":"Wang S, Lin X, Zhu C, et al.. Association between nonalcoholic fatty liver disease and increased glucose-to-albumin ratio in adults without diabetes. Front Endocrinol (Lausanne). 2023, 14:10.3389\/fendo.2023.1287916","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15220","article-title":"Nonalcoholic fatty liver disease and advanced fibrosis in US adults across blood pressure categories","volume":"76","author":"Ciardullo S","year":"2020","unstructured":"Ciardullo S, Monti T, Sala I, Grassi G, Mancia G, Perseghin G. Nonalcoholic fatty liver disease and advanced fibrosis in US adults across blood pressure categories. Hypertension. 2020, 76:562-8. 10.1161\/HYPERTENSIONAHA.120.15220","journal-title":"Hypertension"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01400-1","article-title":"Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems","volume":"20","author":"Schmitz SM","year":"2020","unstructured":"Schmitz SM, Kroh A, Ulmer TF, et al.. Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems. BMC Gastroenterol. 2020, 20:254. 10.1186\/s12876-020-01400-1","journal-title":"BMC Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis AK","year":"2016","unstructured":"Loomis AK, Kabadi S, Preiss D, et al.. Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies. J Clin Endocrinol Metab. 2016, 101:945-52. 10.1210\/jc.2015-3444","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02839-1","article-title":"Higher BMI predicts liver fibrosis among obese children and adolescents with NAFLD-an interventional pilot study","volume":"21","author":"Moran-Lev H","year":"2021","unstructured":"Moran-Lev H, Cohen S, Webb M, Yerushalmy-Feler A, Amir A, Gal DL, Lubetzky R. Higher BMI predicts liver fibrosis among obese children and adolescents with NAFLD-an interventional pilot study. BMC Pediatr. 2021, 21:385. 10.1186\/s12887-021-02839-1","journal-title":"BMC Pediatr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-023-01933-w","article-title":"Association of body fat and muscle tissue parameters with fatty liver disease identified by ultrasound","volume":"22","author":"Song X","year":"2023","unstructured":"Song X, Wu H, Wang B, Sun H. Association of body fat and muscle tissue parameters with fatty liver disease identified by ultrasound. Lipids Health Dis. 2023, 22:167. 10.1186\/s12944-023-01933-w","journal-title":"Lipids Health Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1309\/6VJ4DWGYDU0XYJ8Q","article-title":"Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease","volume":"127","author":"Manco M","year":"2007","unstructured":"Manco M, Marcellini M, Giannone G, Nobili V. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol. 2007, 127:954-60. 10.1309\/6VJ4DWGYDU0XYJ8Q","journal-title":"Am J Clin Pathol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2023.01.001","article-title":"The liver-kidney axis: is serum leptin a potential link in non-alcoholic fatty liver disease-associated chronic kidney disease?","volume":"24","author":"Canbakan M","year":"2023","unstructured":"Canbakan M, Bakkaloglu OK, Atay K, Koroglu E, Tuncer MM, Canbakan B, Senturk H. The liver-kidney axis: is serum leptin a potential link in non-alcoholic fatty liver disease-associated chronic kidney disease?. Arab J Gastroenterol. 2023, 24:52-7. 10.1016\/j.ajg.2023.01.001","journal-title":"Arab J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/234586-comparative-and-predictive-significance-of-serum-leptin-levels-in-non-alcoholic-fatty-liver-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T06:25:10Z","timestamp":1712730310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/234586-comparative-and-predictive-significance-of-serum-leptin-levels-in-non-alcoholic-fatty-liver-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.57943","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,9]]}}}